TY  - ABST
  - Abstract
  - Hayat, A,O'Brien, D,Quinn, F,Keane, F,Parker, I,Kelly, J,Wieczorkowska, M,Crotty, G,Leahy, M,Enright, H,Hennessy, B,Cahill, M,Vandenberghe, EA
  - 2012
  - January
  - Minimal Residual Disease Stratification in Fludarabine Ccyclophosphamide Rituximab (FCR) Therapy in Chronic Lymphocytic Leukaemia (CLL
  - Validated
  - 1
  - ()
DA  - 2012/01
ER  - 

@misc{V206307800,
   = {Abstract},
   = {Hayat,  A and O'Brien,  D and Quinn,  F and Keane,  F and Parker,  I and Kelly,  J and Wieczorkowska,  M and Crotty,  G and Leahy,  M and Enright,  H and Hennessy,  B and Cahill,  M and Vandenberghe,  EA },
   = {2012},
   = {January},
   = {Minimal Residual Disease Stratification in Fludarabine Ccyclophosphamide Rituximab (FCR) Therapy in Chronic Lymphocytic Leukaemia (CLL},
   = {Validated},
   = {1},
   = {()},
  source = {IRIS}
}